119 Ventilator-Associated Pneumonia Posters

Sunday, March 21, 2010: 12:30 PM-2:00 PM
Grand Hall (Hyatt Regency Atlanta)
Type: Poster
971
Clinical Nurse Leader and Ventilator Associated Pneumonia Prevention Program
Carrie J. Tierney, MSN, South Texas Veterans Health Care System, Audie Murphy Division; Patti G. Grota, South Texas Veterans Health Care System, Audie Murphy Division; Jean M. Przykucki, South Texas Veterans Health Care System, Audie Murphy Division; Jose A. Cadena-Zuluaga, South Texas Veterans Health Care System, Audie Murphy Division
972
Reduction Of Ventilator Associated Pneumonia - Steps To Success
Cathy Korn, BSN, MPH, CIC, Boston Medical Center; Carol Sulis, MD, Boston Medical Center; Tamar Barlam, MD, Boston Med Ctr; Charlie O'Donnell, MS, RRT, Boston Medical Center; Julie Silva, RRT, Boston Medical Center; Chris Buckus, RRT, Boston Medical Center; Robert Burke, BSN, MA, CIC, Boston Medical Center; Gail Garvin, BSN, MEd, CIC, Boston Medical Center; Dale Ford, BSN, MPH, CIC, Boston Medical Center
973
The Elimination of Ventilator-associated Pneumonia for 42 Months using Ventilator Bundle and Early Extubation in the Adult Intensive Care Unit
Jeremias Murillo, MD, Saint Barnabas Health Care System; Jennifer LaRosa, MD, Newark Beth Israel Medical Center; Sudheer Nambiar, MD, Newark Beth Israel Medical Center; Deeba Siddiqui, RN, Newark Beth Israel Medical Center; Robert Sigler, RRT, Newark Beth Israel Medical Center; Renita Larang, RN, Newark Beth Israel Medical Center
974
Description of Specific Event Criteria Used to Report Ventilator-Associated Pneumonia to the National Healthcare Safety Network and Implications for a Simplified Definition
Margaret A. Dudeck, MPH, CPH, Centers for Disease Control and Prevention; Shelley S. Magill, MD, PhD, Centers for Disease Control and Prevention; Jonathan R. Edwards, MStat, Centers for Disease Control and Prevention; Teresa C. Horan, MPH, Centers for Disease Control and Prevention
975
Expansion of Bundle Elements to Eliminate Ventilator-Associated Pneumonia
Eileen O'Rourke, MT(ASCP), MPH, The Lankenau Hospital; Mary Lance-Smith, RN, MSN, CCRN, The Lankenau Hospital; Mary Beth Sedwick, BSN, MS, CCRN, The Lankenau Hospital; Susan Gregory, MD, The Lankenau Hospital; Mark Ingerman, MD, The Lankenau Hospital
976
Results of a Quality Improvement Project to Decrease VAP Incidence in the ICU
P. Roxane Armfield, BSN, RN, Atlanta Medical Center
977
Optimizing Management of Ventilator-associated Pneumonia using the 2005 IDSA/ATS Management Guideline
Nasia Safdar, MD, University of Wisconsin Madison; Joshua Medow, MD, University of Wisconsin Madison; Keerthika Chinthapalli, University of Wisconsin Madison; Kenneth Wood, MD, University of Wisconsin Madison; Matthew Hall, MD, Marshfield Clinic; Ann Hundt, University of Wisconsin Madison; Pascale Carayon, University of Wisconsin Madison
978
Using The Clinical Pulmonary Infection Score for Surveillance of Ventilator-associated Pneumonia
Nasia Safdar, MD, University of Wisconsin Madison; Joshua Medow, University of Wisconsin Madison; Rosa Mak, University of Wisconsin Madison; Kenneth Wood, University of Wisconsin Madison
979
Topical Chlorhexidine for Prevention of Ventilator-Associated Pneumonia: A Meta-Analysis
Nasia Safdar, MD, University of Wisconsin Madison; Aiman Ghufran, MD, University of Wisconsin Madison; Germana LM Silva, University of Wisconsin Madison; Piotr Chlebicki, MD, Singapore Medical hospital; J. Drew Zimmer, Northeast regional medical center; Mary AM Rogers, University of Michigan and Ann Arbor VA Medical Center; Sanjay Saint, MD, MPH, University of Michigan and Ann Arbor VA Medical Center
980
Compliance to the practices of control and prevention of ventilator-associated pneumonia in a public teaching hospital
Isa Rodrigues da Silveira Cabral de Menezes, Master, University Hospital of University of Sao Paulo; Rubia Aparecida Lacerda, Doctor, Scholl of Nursing of University of Sao Paulo; Juliana Rizzo Gnatta, Graduating, University of Sao Paulo
982
International Nosocomial Infection Control Consortium report, data summary for 2003-2008: Impact of socio economic level of the country and type of hospital on VAP rates in Adult and Pediatric ICUs of 25 limited resources countries
Victor D. Rosenthal, INICC; Badaruddin A. Memon, Department of Microbiology,S.A.L. University Khairpur; Visanu Thamlikitkul, Siriraj Hospital, Mahidol University; Tarquino Erástides G. Sánchez, Hospital Anchieta LTDA; F. E. Udwadia, Breach Candy Hospital Trust; Nayide Barahona Guzmán, Universidad Simón Bolivar; Grülden Ersoz, Mersin University, Faculty of Medicine; Ilham Abu Khader, Jordan University Hospital; Martha Sobreyra Oropeza, Hospital de la Mujer; Regina Berba, Philippine General Hospital; Fernando Martín Ramírez Wong, Hospital María Auxiliadora; Naoufel Madani, Ibn Sina; Osiel Requejo Pino, Hospital Universitario Gral. Calixto García; Lourdes Dueñas, Hospital Nacional de Niños Benjamin Bloom; Zan Mitrev, Filip II Special Cardiosurgery Hospital; Bijie Hu, Zhongshan Hospital; Vaidotas Gurskis, Kaunas University of Medicine, Children Clinic; SS Kanj, American University of Beirut Medical Center; Trudell Mapp, Clínica Hospital San Fernando; Rosalía Fernández Hidalgo, Hospital Clínica Bíblica; Nejla Ben Jaballah, Hôpital d'Enfants; Lul Raka, National Institute for Public Health of Kosova and Medical School, Prishtina University; Le Thi Anh Thu, Cho Ray Hospital; Achilleas Gikas, University Hospital of Heraklion; María Eugenia Guzmán Siritt, Hospital Militar Dr. Carlos Arvelo
983
Effect of a Silver-Coated Endotracheal Tube on Ventilator-Associated Pneumonia and Medical Resource Utilization in Clinical Practice
Lee E. Morrow, MD, MS, Creighton University Medical Center; Edward P. Mintz, MD, Creighton University Medical Center; Mark A. Malesker, PharmD, Creighton University Medical Center
984
Impact of implementing of non-pharmacological care in prevention of ventilation-associated pneumonia in adults
Ricardo S. Kuchenbecker, PhD, Graduate Studies Program in Epidemiology, and Hospital de Clinicas de Porto Alegre, Federal University of Rio Grande do Sul; Debora Feijo Vieira, ScD, Graduate Studies Program in Epidemiology, and Hospital de Clinicas de Porto Alegre, Federal University of Rio Grande do Sul; Paul D Fisher, Graduate Studies Program in Epidemiology, and Hospital de Clinicas de Porto Alegre, Federal University of Rio Grande do Sul; Mario B Wagner, Graduate Studies Program in Epidemiology, and Hospital de Clinicas de Porto Alegre, Federal University of Rio Grande do Sul; Loriane Konkewicz, Graduate Studies Program in Epidemiology, and Hospital de Clinicas de Porto Alegre, Federal University of Rio Grande do Sul; Nadia Kuplich, Graduate Studies Program in Epidemiology, and Hospital de Clinicas de Porto Alegre, Federal University of Rio Grande do Sul; Rodrigo P Santos, Graduate Studies Program in Epidemiology, and Hospital de Clinicas de Porto Alegre, Federal University of Rio Grande do Sul; Renato Seligman, Graduate Studies Program in Epidemiology, and Hospital de Clinicas de Porto Alegre, Federal University of Rio Grande do Sul; Sergio P. Ribeiro, Graduate Studies Program in Epidemiology, and Hospital de Clinicas de Porto Alegre, Federal University of Rio Grande do Sul
985
The Utility of an Enhanced Bundle and Chlorhexidine Mouthwash in Reducing Ventilator-Associated Pneumonia
Loretta Fauerbach, MS, CIC, Shands Hospital at the University of Florida; Mary Ann Gross, MT, ASCP, CIC, Shands Hospital at the University of Florida; Lennox Archibald, MD, College of Medicine, University of Florida
986
WHAP VAP to Zero: Implementation of an Oral Hygiene Product and Protocol
Jeanne E. Zack, PhD, RN, CIC, Missouri Baptist Medical Center; Angela Recktenwald, MPH, BJC Infection Prevention and Epidemiology Consortium; Beth Schneiderhahn, MSN, ACNS-BC, Missouri Baptist Medical Center; Barb Lamb, RN, BSN, Missouri Baptist Medical Center; Diane Spence, RN, BSN, CCRN, Missouri Baptist Medical Center; Robert S. Martin, MD, Missouri Baptist Medical Center; David A. Striker, MD, FCCP, Missouri Baptist Medical Center; John E. Krettek, MD, PhD, Missouri Baptist Medical Center; Erik R. Dubberke, MD, MSPH, Missouri Baptist Medical Center
987
Changing Rate of Ventilator-Associated Pneumonia Throughout Duration of Mechanical Ventilation
Mary E. Ritchey, PhD, Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill; Michele L. Jonsson Funk, PhD, Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill; Stephen W. Marshall, PhD, Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill; Danica Marinac-Dabic, MD, PhD, Center for Device and Radiologic Health, Food and Drug Administration, Department of Health and Human Services; William A. Rutala, PhD, MPH, University of North Carolina Health Care; David J. Weber, MD, MPH, University of North Carolina Health Care
988
Ventilator-associated pneumonia: opportunity cost analysis
Francyne S. Lopes, Hospital Ernesto Dornelles; Norberto LC Martins, MD, Hospital Ernesto Dornelles; Cassiana Prates, Hospital Ernesto Dornelles; Fernanda P. Nunes, Hospital Ernesto Dornelles; Grasiele Costa, Hospital Ernesto Dornelles; Nair C. Aguilhera, Hospital Ernesto Dornelles; Teresa Sukienik, MD, Irmandade Santa Casa de Misericórdia de Porto Alegre; Joao W. Falk, MD, Universidade Federal do Rio Grande do Sul
989
Can We Reduce Ventilator-Associated Pneumonia Incidence After Cardiac Surgery? : 12-Year Experience of a Teaching Hospital in Chile
M. Cristina Ajenjo, MD, Department of Internal Medicine. Pontificia Universidad Católica de Chile; Alejandra Zambrano, RN, Infection Prevention and Control Committee. Pontificia Universidad Católica de Chile; Ricardo Zalaquett, MD, Department of Cardiovascular Diseases. Pontificia Universidad Católica de Chile; Manuel Irarrázabal, MD, Department of Cardiovascular Diseases. Pontificia Universidad Católica de Chile; Gabriela De la Cerda, RN, Department of Internal Medicine. Pontificia Universidad Católica de Chile; Paula Fernández, Infection Prevention and Control Committee. Pontificia Universidad Católica de Chile; Miriam Barañao, RN, Department of Internal Medicine. Pontificia Universidad Católica de Chile; Marcela Ferrés, MD, Infection Prevention and Control Committee. Pontificia Universidad Católica de Chile; Patricia García, MD, Infection Prevention and Control Committee. Pontificia Universidad Católica de Chile; Carlos Pérez, MD, Department of Internal Medicine. Pontificia Universidad Católica de Chile; Jaime Labarca, MD, Department of Internal Medicine. Pontificia Universidad Catolica de Chile
990
Incidence density of VAP and effects of HOB elevation in 70 hospitals in Shanghai
Bijie Hu, MD, PHD, Zhongshan Hospital of Fudan University; Xiaodong Gao, BM, Zhongshan Hospital of Fudan University; Qing Zhou, MSc, Zhongshan Hospital of Fudan University; Linlin Yu, BM, Zhongshan Hospital of Fudan University; Lili Tao, BM, Zhongshan Hospital of Fudan University; Yiwen Zhang, BM, Zhongshan Hospital of Fudan University; Wenjuan Wang, Zhongshan Hospital of Fudan University; Jinlan Ren, Zhongshan Hospital of Fudan University; Yangwen Cui, Zhongshan Hospital of Fudan University; Yan Shen, Zhongshan Hospital of Fudan University